Inventor · disambiguated record
Roger D. Tung
Also filed as: TUNG PH D ROGER · TUNG ROGER · TUNG ROGER D · TUNG ROGER DENNIS
126 granted patents·78 pending applications·3,088 citations·filing 1990–2024
99Inventor score
Top patents by PatentIndex Score
204 records- 0199US8541436B2Morphinan compoundsTUNG ROGER·Filed 2011·Granted Sep 24, 2013·139 cites·9 claims
- 0299US8188110B2Morphinan compoundsTUNG ROGER·Filed 2011·Granted May 29, 2012·142 cites·11 claims
- 0399US7973049B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2008·Granted Jul 5, 2011·158 cites·30 claims
- 0499US7514068B2Biphenyl-pyrazolecarboxamide compoundsCONCERT PHARMACEUTICALS INC·Filed 2006·Granted Apr 7, 2009·239 cites·9 claims
- 0598US9540367B2Deuterated baricitinibCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Jan 10, 2017·32 cites·19 claims
- 0698US8759394B24-hydroxybutyric acid analogsTUNG ROGER D·Filed 2012·Granted Jun 24, 2014·72 cites·4 claims
- 0798US8461197B24-hydroxybutyric acid analogsTUNG ROGER D·Filed 2010·Granted Jun 11, 2013·78 cites·23 claims
- 0898US5585397ASulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1993·Granted Dec 17, 1996·246 cites·8 claims
- 0997US8987442B2Deuterium-substituted xanthine derivatives and methods of useTUNG ROGER D·Filed 2012·Granted Mar 24, 2015·53 cites·38 claims
- 1097US6617309B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 2001·Granted Sep 9, 2003·103 cites·32 claims
- 1197US6265380B1Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 1999·Granted Jul 24, 2001·200 cites·36 claims
- 1296US9309182B24-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·29 cites·13 claims
- 1396US7388017B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 2003·Granted Jun 17, 2008·77 cites·41 claims
- 1496US6372778B1Sulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1995·Granted Apr 16, 2002·142 cites·13 claims
- 1596US5516797AImmunosuppressive compoundsVERTEX PHARMA·Filed 1994·Granted May 14, 1996·121 cites·8 claims
- 1696US5330993AImmunosuppressive compoundsVERTEX PHARMA·Filed 1991·Granted Jul 19, 1994·143 cites·1 claims
- 1796US5192773AImmunosuppressive compoundsVERTEX PHARMA·Filed 1990·Granted Mar 9, 1993·163 cites·10 claims
- 1895US8263601B2Deuterium substituted xanthine derivativesTUNG ROGER D·Filed 2010·Granted Sep 11, 2012·28 cites·27 claims
- 1995US7678914B2Deuterated benzo[D][1,3]-dioxol derivativesCONCERT PHARMACEUTICALS INC·Filed 2007·Granted Mar 16, 2010·24 cites·4 claims
- 2094US6608067B1Inhibitors of serine proteases, particularly HCV NS3 proteaseVERTEX PHARMA·Filed 2000·Granted Aug 19, 2003·52 cites·13 claims
- 2193US8575221B2Derivatives of dimethylcurcuminMASSE CRAIG E·Filed 2011·Granted Nov 5, 2013·26 cites·18 claims
- 2293US5783701ASulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1995·Granted Jul 21, 1998·49 cites·18 claims
- 2392US10759721B2Deuterated CFTR potentiatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2016·Granted Sep 1, 2020·5 cites·1 claims
- 2492US10668036B2Deuterated analogs of D-serine and uses thereofCONCERT PHARMACEUTICALS INC·Filed 2019·Granted Jun 2, 2020·4 cites·9 claims
- 2592US8563554B2Deuterated pyrazinoisoquinoline compoundsLIU JULIE F·Filed 2010·Granted Oct 22, 2013·8 cites·3 claims
- 2692US7863274B2Deuterium enriched analogues of tadalafil as PDE5 inhibitorsCONCERT PHARMACEUTICALS INC·Filed 2007·Granted Jan 4, 2011·18 cites·4 claims
- 2791US9931343B2Deuterated baricitinibCONCERT PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·4 cites·18 claims
- 2891US9815763B24-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Nov 14, 2017·7 cites·22 claims
- 2991US9051261B24-hydroxybutyric acid analogsTUNG ROGER D·Filed 2013·Granted Jun 9, 2015·10 cites·1 claims
- 3091US8759383B2Inhibitors of cholesterol ester transfer proteinTUNG ROGER·Filed 2008·Granted Jun 24, 2014·4 cites·15 claims
- 3191US6436989B1Prodrugs of aspartyl protease inhibitorsVERTEX PHARMA·Filed 1997·Granted Aug 20, 2002·62 cites·12 claims
- 3291US5723490ATHF-containing sulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1995·Granted Mar 3, 1998·108 cites·18 claims
- 3390US10040748B24-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2016·Granted Aug 7, 2018·6 cites·13 claims
- 3489US11473123B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2020·Granted Oct 18, 2022·1 cites·12 claims
- 3589US11161798B24-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2020·Granted Nov 2, 2021·2 cites·22 claims
- 3689US10343968B2Deuterated idebenoneCONCERT PHARMACEUTICALS INC·Filed 2018·Granted Jul 9, 2019·2 cites·10 claims
- 3789US5622970AImmunosuppressive compoundsVERTEX PHARMA·Filed 1995·Granted Apr 22, 1997·61 cites·10 claims
- 3888US12319954B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2023·Granted Jun 3, 2025·0 cites·17 claims
- 3988US10017445B2Deuterated idebenoneCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Jul 10, 2018·3 cites·19 claims
- 4088US8748450B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Jun 10, 2014·6 cites·7 claims
- 4187US9035050B2Substituted xanthine derivativesCONCERT PHARMACEUTICALS INC·Filed 2013·Granted May 19, 2015·7 cites·22 claims
- 4287US5912269AButyrate prodrugs derived from lactic acidVERTEX PHARMA·Filed 1996·Granted Jun 15, 1999·34 cites·12 claims
- 4386US10532971B24-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2017·Granted Jan 14, 2020·3 cites·24 claims
- 4486US7855204B2Derivatives of gefitinibCONCERT PHARMACEUTICALS INC·Filed 2009·Granted Dec 21, 2010·7 cites·10 claims
- 4586US5977137ASulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1998·Granted Nov 2, 1999·26 cites·21 claims
- 4686US5665774AImmunosuppressive compoundsFiled 1993·Granted Sep 9, 1997·42 cites·18 claims
- 4785US9868976B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2016·Granted Jan 16, 2018·3 cites·16 claims
- 4885US9072711B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Jul 7, 2015·4 cites·12 claims
- 4985US8796267B2Oxazolidinone derivatives and methods of useTUNG ROGER·Filed 2008·Granted Aug 5, 2014·4 cites·10 claims
- 5085US8343980B2Quinazoles useful as modulators of ion channelsVERTEX PHARMA·Filed 2010·Granted Jan 1, 2013·8 cites·9 claims
Showing the top 50 of 204 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roger D. Tung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →